Bardia Nourbakhsh

Research output

Research output per year 2007 2016 2017 2018 2021 2024

• 42 Article
• 4 Comment/debate
• 4 Letter
• 4 Review article
• 1 More
  • 1 Chapter

Research output per year

Research output per year

Search results

• 2024

  Association between demographics, socioeconomics, and disease-related factors and the perception of stigma in people with MS

  Ghajarzadeh, M., Fitzgerald, K., Mowry, E. M. & Nourbakhsh, B., Feb 2024, In: Multiple Sclerosis Journal. 30, 2, p. 238-246 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Demography 73%
  • Logistic Models 49%
  • Biomedical Technology 23%
  • Unemployment 23%

• Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis

  Simpson, A. C., Hu, C., Mowry, E. M., Naismith, R. T., Fitzgerald, K. & Nourbakhsh, B., 2024, (Accepted/In press) In: Multiple Sclerosis Journal.

  Research output: Contribution to journal › Article › peer-review
• 2023

  Design recommendations for studies that evaluate multiple sclerosis fatigue interventions

  Ghajarzadeh, M., Waubant, E. & Nourbakhsh, B., 2023, In: Frontiers in Psychiatry. 14, 1287344.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Low-dose ketamine infusion for the treatment of multiple sclerosis fatigue (INKLING-MS): Study protocol for a randomized, double-blind, active placebo-controlled phase II trial

  Ghajarzadeh, M., Roman, S., Vega, L. & Nourbakhsh, B., Mar 2023, In: Contemporary Clinical Trials. 126, 107106.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ketamine 100%
  • Multiple Sclerosis 80%
  • Fatigue 76%
  • Placebos 62%
  • Midazolam 29%

• Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis

  Virupakshaiah, A., Ladakis, D. C., Nourbakhsh, B., Bhargava, P., Dilwali, S., Schoeps, V., Borkowski, K., Newman, J. W. & Waubant, E., Jul 2023, In: Multiple Sclerosis Journal. 29, 8, p. 936-944 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Lipids 74%
  • Pediatrics 72%
  • Recurrence 64%
  • Serum 51%
• 2022

  Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis

  Cordano, C., Nourbakhsh, B., Yiu, H. H., Papinutto, N., Caverzasi, E., Abdelhak, A., Oertel, F. C., Beaudry-Richard, A., Santaniello, A., Sacco, S., Bennett, D. J., Gomez, A., Sigurdson, C. J., Hauser, S. L., Magliozzi, R., Cree, B. A. C., Henry, R. G. & Green, A. J., Oct 11 2022, In: Neurology. 99, 15, p. E1685-E1693

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Atrophy 98%
  • Gray Matter 57%
  • Ganglia 55%
  • Relapsing-Remitting Multiple Sclerosis 35%

• Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease

  Ladakis, D. C., Gould, J., Khazen, J. M., Lefelar, J. M., Tarpey, S., Bies, C. J., Salky, R., Fitzgerald, K. C., Bhargava, P., Nourbakhsh, B. & Sotirchos, E. S., Oct 2022, In: Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Myelin-Oligodendrocyte Glycoprotein 100%
  • Fatigue 58%
  • Antibodies 38%
  • Optic Neuritis 14%
  • Neuromyelitis Optica 7%

• N-acetyl cysteine as a neuroprotective agent in progressive multiple sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial

  Schoeps, V. A., Graves, J. S., Stern, W. A., Zhang, L., Nourbakhsh, B., Mowry, E. M., Henry, R. G. & Waubant, E., Nov 2022, In: Contemporary Clinical Trials. 122, 106941.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuroprotective Agents 100%
  • Cysteine 92%
  • Multiple Sclerosis 86%
  • Placebos 67%
  • Oxidative Stress 28%

• The Role of Remote Monitoring in Evaluating Fatigue in Multiple Sclerosis: A Review

  Block, V. J., Bove, R. & Nourbakhsh, B., Jun 27 2022, In: Frontiers in Neurology. 13, 878313.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Fatigue 95%
  • Wearable Electronic Devices 16%
  • Smartphone 13%
  • Self Report 10%
• 2021

  A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine

  Krysko, K. M., Bischof, A., Nourbakhsh, B., Henry, R. G., Revirajan, N., Manguinao, M., Nguyen, K., Akula, A., Li, Y. & Waubant, E., Apr 2021, In: Annals of Clinical and Translational Neurology. 8, 4, p. 811-824 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cysteine 100%
  • Fatigue 89%
  • Placebos 42%
  • Glutathione Disulfide 32%
  • Gyrus Cinguli 18%

• Biosensor vital sign detects multiple sclerosis progression

  Krysko, K. M., Akhbardeh, A., Arjona, J., Nourbakhsh, B., Waubant, E., Antoine Gourraud, P. & Graves, J. S., Jan 2021, In: Annals of Clinical and Translational Neurology. 8, 1, p. 4-14 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Chronic Progressive Multiple Sclerosis 100%
  • Biosensing Techniques 88%
  • Vital Signs 81%
  • Multiple Sclerosis 64%
  • Extremities 42%

• COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis

  Mantero, V., Abate, L., Basilico, P., Balgera, R., Salmaggi, A., Nourbakhsh, B. & Cordano, C., Jun 2021, In: Journal of neurology. 268, 6, p. 2023-2025 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  11 Scopus citations

• Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid

  Gu, W., Rauschecker, A. M., Hsu, E., Zorn, K. C., Sucu, Y., Federman, S., Gopez, A., Arevalo, S., Sample, H. A., Talevich, E., Nguyen, E. D., Gottschall, M., Nourbakhsh, B., Gold, C. A., Cree, B. A. C., Douglas, V. C., Richie, M. B., Shah, M. P., Josephson, S. A., Gelfand, J. M., & 6 othersMiller, S., Wang, L., Tihan, T., Derisi, J. L., Chiu, C. Y. & Wilson, M. R., Nov 2021, In: JAMA Neurology. 78, 11, p. 1355-1366 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Metagenomics 100%
  • High-Throughput Nucleotide Sequencing 77%
  • Cerebrospinal Fluid 70%
  • Central Nervous System Neoplasms 70%
  • Aneuploidy 34%

• Ethical considerations in the treatment of multiple sclerosis fatigue

  Nourbakhsh, B., Waubant, E., Evers, A. W. M. & Solomon, A. J., Sep 2021, In: Multiple Sclerosis and Related Disorders. 54, 103129.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Multiple Sclerosis 100%
  • Fatigue 95%
  • Placebo Effect 40%
  • Placebos 22%
  • Therapeutics 18%

• Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism

  Fitzgerald, K. C., Smith, M. D., Kim, S., Sotirchos, E. S., Kornberg, M. D., Douglas, M., Nourbakhsh, B., Graves, J., Rattan, R., Poisson, L., Cerghet, M., Mowry, E. M., Waubant, E., Giri, S., Calabresi, P. A. & Bhargava, P., Oct 19 2021, In: Cell Reports Medicine. 2, 10, 100424.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Aromatic Amino Acids 100%
  • Aromatic Amino Acid 81%
  • Small Cytoplasmic RNA 62%
  • Multiple Sclerosis 61%
  • Metabolic 56%

• Multiple Sclerosis Is Rare in Epstein–Barr Virus–Seronegative Children with Central Nervous System Inflammatory Demyelination

  Nourbakhsh, B., Cordano, C., Asteggiano, C., Ruprecht, K., Otto, C., Rutatangwa, A., Lui, A., Hart, J., Flanagan, E. P., James, J. A. & Waubant, E., Jun 2021, In: Annals of neurology. 89, 6, p. 1234-1239 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Demyelinating Diseases 100%
  • Multiple Sclerosis 83%
  • Central Nervous System 70%
  • Viruses 63%
  • Child 41%

• Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue

  Fitzgerald, K. C., Morris, B., Soroosh, A., Balshi, A., Maher, D., Kaplin, A. & Nourbakhsh, B., May 2021, In: Multiple Sclerosis Journal. 27, 6, p. 942-953 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ketamine 100%
  • Fatigue 76%
  • Placebos 62%
  • Multiple Sclerosis 29%
  • Therapeutics 14%
  1 Scopus citations

• Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial

  Nourbakhsh, B., Revirajan, N., Morris, B., Cordano, C., Creasman, J., Manguinao, M., Krysko, K., Rutatangwa, A., Auvray, C., Aljarallah, S., Jin, C., Mowry, E., McCulloch, C. & Waubant, E., Jan 2021, In: The Lancet Neurology. 20, 1, p. 38-48 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Modafinil 100%
  • Amantadine 93%
  • Methylphenidate 85%
  • Multiple Sclerosis 60%
  • Fatigue 58%
  4 Scopus citations

• Serious side effects of amantadine: Rethinking the benefits and risks of medications for MS fatigue

  Nourbakhsh, B., Dec 2021, In: Multiple Sclerosis Journal. 27, 14, p. 2290 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review
• 2020

  B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran

  Safavi, F., Nourbakhsh, B. & Azimi, A. R., Aug 2020, In: Multiple Sclerosis and Related Disorders. 43, 102195.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Iran 100%
  • Cell- and Tissue-Based Therapy 97%
  • Multiple Sclerosis 90%
  • Epidemics 88%
  • B-Lymphocytes 78%
  43 Scopus citations

• Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation

  Bhargava, P., Smith, M. D., Mische, L., Harrington, E., Fitzgerald, K. C., Martin, K., Kim, S., Reyes, A. A., Gonzalez-Cardona, J., Volsko, C., Tripathi, A., Singh, S., Varanasi, K., Lord, H. N., Meyers, K., Taylor, M., Gharagozloo, M., Sotirchos, E. S., Nourbakhsh, B., Dutta, R., & 3 othersMowry, E. M., Waubant, E. & Calabresi, P. A., Jul 1 2020, In: Journal of Clinical Investigation. 130, 7, p. 3467-3482 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Bile Acids and Salts 100%
  • Multiple Sclerosis 85%
  • tauroursodeoxycholic acid 45%
  • Astrocytes 26%
  • Microglia 19%
  8 Scopus citations

• Novel MS vital sign: multi-sensor captures upper and lower limb dysfunction

  Akhbardeh, A., Arjona, J. K., Krysko, K. M., Nourbakhsh, B., Gourraud, P. A. & Graves, J. S., Mar 1 2020, In: Annals of Clinical and Translational Neurology. 7, 3, p. 288-295 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Vital Signs 100%
  • Upper Extremity 81%
  • Lower Extremity 72%
  • Extremities 66%
  2 Scopus citations
• 2019

  Multiple sclerosis risk factors and pathogenesis

  Nourbakhsh, B. & Mowry, E. M., Jun 1 2019, In: CONTINUUM Lifelong Learning in Neurology. 25, 3, p. 596-610 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Multiple Sclerosis 100%
  • Vitamin D Deficiency 42%
  • Demyelinating Diseases 39%
  • Obesity 26%
  • Epstein-Barr Virus Infections 22%
  14 Scopus citations

• PRNFL as a marker of disability worsening in the medium/long term in patients with MS

  Cordano, C., Nourbakhsh, B., Devereux, M., Damotte, V., Bennett, D., Hauser, S. L., Cree, B. A. C., Gelfand, J. M. & Green, A. J., Mar 1 2019, In: Neurology: Neuroimmunology and NeuroInflammation. 6, 2, e533.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  3 Scopus citations
• 2018

  Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

  Nourbakhsh, B., Bhargava, P., Tremlett, H., Hart, J., Graves, J. & Waubant, E., Oct 2018, In: Annals of Clinical and Translational Neurology. 5, 10, p. 1211-1221 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Tryptophan 100%
  • Multiple Sclerosis 82%
  • Pediatrics 60%
  • Kynurenine 28%
  • Metabolomics 23%
  18 Scopus citations

• Determining the etiology of internuclear ophthalmoplegia in a patient with a cardiac pacemaker and complex neurological presentation

  Nourbakhsh, B., Cordano, C. & Renthal, W., Oct 2018, In: Journal of Clinical Neurology (Korea). 14, 4, p. 574-576 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis

  on behalf of the Network of Pediatric Multiple Sclerosis Centers., May 2018, In: Multiple Sclerosis and Related Disorders. 22, p. 103-107 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Pediatrics 72%
  • Poaceae 40%
  • Pacifiers 24%
  • Pediculus 24%

• Heterogeneity in association of remote herpesvirus infections and pediatric MS

  On behalf of the US Network of Pediatric MS Centers, Oct 2018, In: Annals of Clinical and Translational Neurology. 5, 10, p. 1222-1228 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Herpesviridae Infections 100%
  • Multiple Sclerosis 68%
  • Pediatrics 50%
  • HLA-DRB1 Chains 41%
  • Human Herpesvirus 1 25%
  10 Scopus citations

• Occipital Headache in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)

  Cordano, C., López, G. Y., Bollen, A. W. & Nourbakhsh, B., Mar 2018, In: Headache. 58, 3, p. 458-459 2 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• Osteopathic manipulative therapy and multiple sclerosis: A proof-of-concept study

  Cordano, C., Armezzani, A., Veroni, J., Pardini, M., Sassos, D., Infante, M. T., Tacchino, A., Lapucci, C., Cellerino, M., Calabrò, V., Ciullo, L. & Nourbakhsh, B., Aug 2018, In: Journal of the American Osteopathic Association. 118, 8, p. 531-536 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Musculoskeletal Manipulations 100%
  • Proof of Concept Study 96%
  • Multiple Sclerosis 68%
  • Fatigue 51%
  • Anxiety 33%

• Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis

  Gajofatto, A., Nourbakhsh, B., Benedetti, M. D. & Waubant, E., May 1 2018, In: Journal of neurology, neurosurgery, and psychiatry. 89, 5, p. 550-552 3 p.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial

  Nourbakhsh, B., Revirajan, N. & Waubant, E., Jan 2018, In: Contemporary Clinical Trials. 64, p. 67-76 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Modafinil 100%
  • Amantadine 93%
  • Methylphenidate 85%
  • Cross-Over Studies 62%
  • Multiple Sclerosis 60%
  7 Scopus citations
• 2017

  Clinical Reasoning: A 16-year-old girl with subacute weakness and sensory loss

  Quintanilla-Bordás, C., Nourbakhsh, B., Strober, J., Raffel, C. & Waubant, E., Jun 6 2017, In: Neurology. 88, 23, p. e225-e229

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Scopus citations

• Continuous daily assessment of multiple sclerosis disability using remote step count monitoring

  Block, V. J., Lizée, A., Crabtree-Hartman, E., Bevan, C. J., Graves, J. S., Bove, R., Green, A. J., Nourbakhsh, B., Tremblay, M., Gourraud, P. A., Ng, M. Y., Pletcher, M. J., Olgin, J. E., Marcus, G. M., Allen, D. D., Cree, B. A. C. & Gelfand, J. M., Feb 1 2017, In: Journal of neurology. 264, 2, p. 316-326 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Chronic Progressive Multiple Sclerosis 78%
  • Walking 74%
  • Walk Test 34%
  39 Scopus citations

• Extensive Involvement of Multiple Cranial and Spinal Nerves in Lymphomatous Meningitis

  Cordano, C., Nourbakhsh, B., Brown, E. & Glastonbury, C., Sep 1 2017, In: Canadian Journal of Neurological Sciences. 44, 5, p. 599-600 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Scopus citations

• Homonymous hemianopia as the first sign of posterior cortical atrophy

  Cordano, C., Giulia, A., Alessandro, L., Cellerino, M., Nourbakhsh, B., Flavio, N. & Fabio, B., Feb 15 2017, In: Journal of the Neurological Sciences. 373, p. 38-40 3 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Maternal and perinatal exposures are associated with risk for pediatric-onset multiple sclerosis

  Network of Pediatric Multiple Sclerosis Centers, Apr 2017, In: Pediatrics. 139, 4, e20162838.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Maternal Exposure 100%
  • Multiple Sclerosis 69%
  • Pediatrics 50%
  • Pregnancy 21%
  • Confidence Intervals 20%
  11 Scopus citations

• Serum neurofilament is associated with progression of brain atrophy and disability in early MS

  Kuhle, J., Nourbakhsh, B., Grant, D., Morant, S., Barro, C., Yaldizli, Ö., Pelletier, D., Giovannoni, G., Waubant, E. & Gnanapavan, S., Feb 28 2017, In: Neurology. 88, 9, p. 826-831 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Intermediate Filaments 100%
  • Riluzole 89%
  • Atrophy 78%
  • Light 64%
  • Brain 44%
  97 Scopus citations
• 2016

  Clinical reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma

  Vila-Bedmar, S., Nourbakhsh, B., Anzalone, S. & Waubant, E., Apr 12 2016, In: Neurology. 86, 15, p. e161-e165

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Dietary salt intake and time to relapse in paediatric multiple sclerosis

  Network of Pediatric Multiple Sclerosis Centers, Dec 1 2016, In: Journal of Neurology, Neurosurgery and Psychiatry. 87, 12, p. 1350-1353 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Multiple Sclerosis 100%
  • Salts 99%
  • Pediatrics 72%
  • Sodium 66%
  • Recurrence 64%
  37 Scopus citations

• Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study

  Nourbakhsh, B., Julian, L. & Waubant, E., Sep 1 2016, In: European Journal of Neurology. 23, 9, p. 1482-1486 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Fatigue 95%
  • Longitudinal Studies 94%
  • Quality of Life 72%
  • Cognition 29%
  40 Scopus citations

• Longitudinal associations between brain structural changes and fatigue in early MS

  Nourbakhsh, B., Azevedo, C., Nunan-Saah, J., Maghzi, A. H., Spain, R., Pelletier, D. & Waubant, E., Jan 2016, In: Multiple Sclerosis and Related Disorders. 5, p. 29-33 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Fatigue 95%
  • Brain 55%
  • Gray Matter 19%
  • White Matter 17%
  25 Scopus citations

• Longitudinal associations between MRI and cognitive changes in very early MS

  Nourbakhsh, B., Nunan-Saah, J., Maghzi, A. H., Julian, L. J., Spain, R., Jin, C., Lazar, A., Pelletier, D. & Waubant, E., Jan 2016, In: Multiple Sclerosis and Related Disorders. 5, p. 47-52 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Multiple Sclerosis 100%
  • Magnetic Resonance Imaging 75%
  • Riluzole 56%
  • Cognitive Dysfunction 46%
  • Brain 27%
  19 Scopus citations

• Neurodegeneration and remyelination in multiple sclerosis

  Nourbakhsh, B. & Waubant, E., 2016, Multiple Sclerosis: A Mechanistic View. Elsevier Inc., p. 311-337 27 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Remyelination 100%
  • Multiple Sclerosis 66%
  • Oligodendrocyte Precursor Cells 33%
  • Oligodendroglia 27%
  • Demyelinating Diseases 26%
  3 Scopus citations

• Rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment

  Hatcher, S. E., Waubant, E., Nourbakhsh, B., Crabtree-Hartman, E. & Graves, J. S., Jul 2016, In: JAMA Neurology. 73, 7, p. 790-794 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Fingolimod Hydrochloride 100%
  • Withholding Treatment 86%
  • Multiple Sclerosis 63%
  • Recurrence 13%
  • Therapeutics 11%
  101 Scopus citations

• Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis

  Nourbakhsh, B., Azevedo, C., Maghzi, A. H., Spain, R., Pelletier, D. & Waubant, E., Jul 15 2016, In: Journal of the Neurological Sciences. 366, p. 229-233 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Gray Matter 100%
  • Multiple Sclerosis 87%
  • Walking 86%
  • Putamen 82%
  • Walk Test 59%
  6 Scopus citations
• 2015

  Association between glutamate blockade and fatigue in patientswith multiple sclerosis

  Nourbakhsh, B., Revirajan, N. & Waubant, E., Nov 2015, In: JAMA Neurology. 72, 11, p. 1374-1375 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Scopus citations
• 2014

  Isoniazid in autoimmunity: A trigger for multiple sclerosis?

  Nourbakhsh, B. & Stuve, O., Sep 2014, In: Therapeutic Advances in Neurological Disorders. 7, 5, p. 253-256 4 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Chronic Progressive Multiple Sclerosis 100%
  • Isoniazid 82%
  • Prodrugs 80%
  • Autoimmunity 70%
  • Peroxidase 69%
  3 Scopus citations
• 2013

  Clinical Reasoning: A woman with recurrent aphasia and visual field defects

  Nourbakhsh, B., Rojas, J. C., Banerjee, C., Novakovic, R. L. & Warnack, W., Nov 5 2013, In: Neurology. 81, 19, p. e141-e144

  Research output: Contribution to journal › Article › peer-review

• Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis

  Li, H., Gonnella, P., Safavi, F., Vessal, G., Nourbakhsh, B., Zhou, F., Zhang, G. X. & Rostami, A., Jan 15 2013, In: Journal of Neuroimmunology. 254, 1-2, p. 28-38 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Zymosan 100%
  • Autoimmune Experimental Encephalomyelitis 94%
  • Glucans 17%
  • Adoptive Transfer 15%
  • Regulatory T-Lymphocytes 13%
  19 Scopus citations